Speaker illustration

Doctor Josip Andjelo Borovac

University Hospital Center Split, Split (Croatia)

Member of:

European Society of Cardiology
EAPCI
Heart Failure Association

Dr. Josip A. Borovac (MD, PhD, BSc) is a research associate at the Department of Pathophysiology, University of Split School of Medicine, and a cardiology fellow at the Clinic for Heart and Vascular Diseases, University Hospital of Split, Croatia. He is an active member of the Croatian Cardiac Society Working group on Heart Failure, a national representative of Croatia in the Heart Failure Association's Heart Failure Specialists of Tomorrow (ESC HFA HoT) Committee, and ESC Working Group on Thrombosis Young Researchers (YTRG) Nucleolus member. Josip has published a substantial amount of publications in areas of his scientific and clinical interest including heart failure, acute coronary syndromes, coronary artery disease, novel cardiometabolic biomarkers, and advanced electrocardiography related to ischemic heart disease. He currently serves on the Editorial boards of BMC Cardiovascular Disorders (Springer Nature), Cardiac Failure Review (Radcliffe Cardiology), and Medicine (LWW).

The association of CABG vs. PCI on echocardiographic indices of global longitudinal strain and myocardial work in patients with HFrEF and ischemic cardiomyopathy: a pilot study

Event: Heart Failure 2022

Topic: Imaging

Session: Heart Failure ePosters - focus on Chronic Heart Failure 4

Thumbnail

Patients with non-ischemic dilated cardiomyopathy and AF exhibit worse global longitudinal strain and reduced work index and constructive work of the myocardium compared to those without AF

Event: Heart Failure 2022

Topic: Heart Failure in Atrial Fibrillation

Session: Heart Failure ePosters - focus on Arrhythmias and device

Thumbnail

Efficacy of propafenone vs. amiodarone in pharmacological cardioversion of recent-onset atrial fibrillation to sinus rhythm: a pooled meta-analysis of 9 randomized controlled trials

Event: ESC Congress 2021 - The Digital Experience

Topic: Antiarrhythmic Pharmacotherapy

Session: Pharmacology and pharmacotherapy e-posters

Thumbnail

The effect of P2Y12 inhibitor pretreatment vs. no pretreatment on ischemic outcomes among patients with NSTE-ACS: an updated meta-analysis and meta-regression pooling 106,405 patients from 12 studies

Event: ESC Congress 2021 - The Digital Experience

Topic: Pharmacotherapy

Session: Coronary Artery Disease (Chronic)/Chronic Coronary Syndromes ePosters

Thumbnail

The effect of P2Y12 inhibitor pretreatment vs. no pretreatment on major bleeding among patients with NSTE-ACS: an updated meta-analysis and meta-regression pooling 41,548 patients from 11 studies

Event: ESC Congress 2021 - The Digital Experience

Topic: Pharmacotherapy

Session: Coronary Artery Disease (Chronic)/Chronic Coronary Syndromes ePosters

Thumbnail

Risk of hyperkalemia with sacubitril/valsartan vs. RAAS inhibitor use in heart failure with reduced and preserved ejection fraction: a meta-analysis of 6 RCTs including 17,362 patients

Event: Heart Failure 2021 Online Congress

Topic: Angiotensin-Renin-Bradykinin System

Session: ePoster session

Thumbnail

Use of SGLT2 inhibitors and the incidence of urinary tract infections in patients with heart failure: a pooled analysis of four trials including 26,838 patients

Event: Heart Failure 2021 Online Congress

Topic: Antidiabetic Pharmacotherapy

Session: ePoster session

Thumbnail

The predictive value of CHA2DS2-VASc score on adverse in-hospital outcomes among patients with the acute coronary syndrome and atrial fibrillation who undergo PCI

Event: ESC CONGRESS 2020 - The Digital Experience

Topic: Epidemiology, Prognosis, Outcome

Session: Epidemiology, Prognosis, Outcome in Acute Coronary Syndromes – New Insights

Thumbnail

Catestatin and chronic heart failure patients with an acute decompensation event: clinical characteristics and 30-day all-cause mortality

Event: ESC CONGRESS 2019

Topic: Biomarkers

Session: Biomarkers in heart failure

Thumbnail

Percutaneous coronary intervention and clinical outcomes in patients with lymphoma: a 10-year period United States nationwide inpatient sample (NIS) analysis

Event: ESC CONGRESS 2019

Topic: Cardio-Oncology

Session: Cardio-oncology I

Thumbnail

This platform is supported by

logo Novo Nordisk